SETD5

protein-coding

SET domain containing 5, the group of SET domain containing

Gene summary

This function of this gene has yet to be determined but based on sequence similarity to other SET domain proteins it may function as a histone methyltransferase. Mutations in this gene have been associated with an autosomal dominant form of intellectual disability. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2017]

MANE transcript

NM_001080517.3

Inheritance

AD

ClinVar variants

P:309U:598B:370

Top phenotype

Intellectual developmental disorder, autosomal dominant 23

gnomAD constraint

pLI —, LoF o/e 0.13

Max pathogenic AF

—

Genomic locus

chr3:9,397,615-9,479,240

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~81.6 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiencySTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0014336

Submitter: PanelApp Australia

intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiencySTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0014336

Submitter: Labcorp Genetics (formerly Invitae)

intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiencyDEFINITIVE

Inheritance Pattern: AD

Disease ID:MONDO:0014336

Submitter: G2P

syndromic complex neurodevelopmental disorderDEFINITIVE

Inheritance Pattern: AD

Disease ID:MONDO:0800439

Submitter: ClinGen

*SETD5* was first reported in relation to autosomal dominant syndromic complex neurodevelopmental disorder in 2013 (PMID: 24680889). Phenotypic features often reported in probands include: dysmorphic features, leg length discrepancies, feeding difficulties, developmental delays, autism, skeletal anomalies, and congenital malformations of various organ systems. This curation includes 19 variants (frameshift, deletions, missense, splice site) reported probands with phenotypic similarity (PMIDs: 28881385, 028120103, 28263952, 26482601, 29158550, 27375234, 32793091, 31656537, 29805509, 24680889, 25138099, 28549204). More evidence is available in the literature but the maximum score for genetic evidence (12 points) has been reached. Of note, three individuals with variants in *SETD5* and a distinct phenotype consistent with Moya Moya Disease, a rare, progressive cerebrovascular disorder caused by blocked arteries in the basal ganglia have also been reported, however that association has not been confirmed or reported again (PMID: 31474762). These individuals with Moya Moya did not have any neurodevelopmental delays and therefore were not scored in this curation. The mechanism of pathogenicity appears to be loss-of-function. In summary, there is definitive evidence supporting the relationship between *SETD5* and autosomal dominant syndromic complex neurodevelopmental disorder. This has been repeatedly demonstrated in the clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on the meeting date July 27, 2023 (SOP Version 9).

Clinical Genomic Database (CGD)

Intellectual developmental disorder, autosomal dominant 23AD

Manifestation: Craniofacial; Musculoskeletal; Neurologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 24680889Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to SETD5 variants in ClinVar

31 Conditions Cataloged
not providedTotal: 1100
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiencyTotal: 256
Inborn genetic diseasesTotal: 224
SETD5-related disorderTotal: 65
not specifiedTotal: 49
Intellectual disabilityTotal: 10
See casesTotal: 8
Neurodevelopmental disorderTotal: 3

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_001080517.3. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
2
clinvar
12
clinvar
184
clinvar
22
clinvar
220
missense
8
clinvar
29
clinvar
559
clinvar
156
clinvar
6
clinvar
758
nonsense
52
clinvar
25
clinvar
5
clinvar
1
clinvar
83
start loss
0
frameshift
116
clinvar
45
clinvar
13
clinvar
1
clinvar
175
splice donor/acceptor (+/-2bp)
14
clinvar
18
clinvar
9
clinvar
41
Total190119598342281277

Highest pathogenic variant AF is 0.000006369896

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 93 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_001080517.3RefSeqNP_001073986.121MANE Select
ENST00000402198.7EnsemblENSP00000385852.221MANE Select
NM_001292043.2RefSeqNP_001278972.119Standard
NM_001349451.2RefSeqNP_001336380.119Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
setd5Danio rerio

Structure: head

Quality: decreased size

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Histone Modifications

Biological Process

  • covalent chromatin modification
  • regulation of histone acetylation
  • regulation of chromatin organization

Cellular Component

  • nucleus
  • nucleoplasm
  • Cdc73/Paf1 complex

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000402198
Coding exons
21
Length
81626
Individuals with no LoFs
124610
Homozygous LoFs
0
Heterozygous LoFs
32
Defined
124642
p
0.000128
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense1.136837720.8850.00004309258
Missense (PolyPhen)177311.90.567483567
Synonymous-0.6842962811.050.00001442959
Loss of Function6.70969.10.1300.00000434803

Population LoF Frequency

PopulationCAFp-valueStatus
African0.00100.0010notable
Latino/Admixed American0.0000290.000029rare
Ashkenazi Jewish0.000200.00020rare
East Asian0.000110.00011rare
Finnish0.0000460.000046rare
European (Non-Finnish)0.0000350.000035rare
South Asian0.000130.00013rare
Other0.000330.00033rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Probable transcriptional regulator that acts via the formation of large multiprotein complexes that modify and/or remodel the chromatin. Acts as a regulator of histone acetylation during gene transcription. {ECO:0000250|UniProtKB:Q5XJV7}.;
Disease
DISEASE: Mental retardation, autosomal dominant 23 (MRD23) [MIM:615761]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD23 patients manifest moderate to severe intellectual disability with additional variable features of brachycephaly, a low hairline, depressed nasal bridge, prominent high nasal root, tubular nose, upslanting palpebral fissures, long and smooth philtrum, micrognathia, thin upper lip, and crowded teeth. Behavioral problems, including obsessive-compulsive disorder, hand flapping with ritualized behavior, and autism, are prominent features. {ECO:0000269|PubMed:24680889, ECO:0000269|PubMed:25138099, ECO:0000269|PubMed:27375234, ECO:0000269|PubMed:28549204}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.107

Intolerance Scores

LoFtool
0.0174
RVIS EVS
-0.79
RVIS percentile EVS
12.6

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Indispensability pred.
E
Indispensability score
0.797

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.